Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2025

Caitlin E. Cox

November 03, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News TCT 2023

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

Michael O'Riordan

October 26, 2023

News Daily News

DOACs Safe, Effective in Subset of Valvular AF Patients

Shelley Wood

March 31, 2021

News Daily News

Television Viewing Time Linked to Higher Mortality From Pulmonary Embolism

L.A. McKeown

July 25, 2016

News Industry News

Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions

August 24, 2015

News Daily News

肺栓塞发作后，二级抗凝效果未持续

L.A. McKeown

July 13, 2015

News Industry News

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

July 13, 2015

News Daily News

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

L.A. McKeown

July 13, 2015

News Daily News

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

L.A. McKeown

July 13, 2015

News Industry News

Daiichi Sankyo gets EU OK for Lixiana anticoagulant

June 26, 2015

News Industry News

Idarucizumab Reverses the Anticoagulant Effect of Dabigatran Within Minutes in Patient Study

June 22, 2015

News Conference News ACC 2014

Melody Valve Post-Approval Study Demonstrates Results Better than Originally Predicted

Yael L. Maxwell

March 30, 2014

News Daily News

Ultrasound-Accelerated Thrombolysis More Effective Than Heparin Alone for Intermediate PE

January 01, 2014

Advertisement

TCTMD’s Top 10 Most Popular Stories for October 2025

What’s Going to Be Hot at TCT 2025

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

DOACs Safe, Effective in Subset of Valvular AF Patients

Television Viewing Time Linked to Higher Mortality From Pulmonary Embolism

Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions

肺栓塞发作后，二级抗凝效果未持续

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

Daiichi Sankyo gets EU OK for Lixiana anticoagulant

Idarucizumab Reverses the Anticoagulant Effect of Dabigatran Within Minutes in Patient Study

Melody Valve Post-Approval Study Demonstrates Results Better than Originally Predicted

Ultrasound-Accelerated Thrombolysis More Effective Than Heparin Alone for Intermediate PE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content